Profil
James Scott Whitehurst formerly worked at Amgen, Inc., as Vice President-Finance & Operations from 2008 to 2016, XBiotech, Inc., as Chief Financial Officer, Elanco Tiergesundheit AG, as Chief Financial Officer from 2005 to 2006, and Keane Consulting, Inc., as Chief Financial Officer from 2005 to 2006.
Ehemalige bekannte Positionen von James Scott Whitehurst
Unternehmen | Position | Ende |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | 01.04.2016 |
Keane Consulting, Inc. | Finanzdirektor/CFO | 01.01.2006 |
Elanco Tiergesundheit AG
Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Finanzdirektor/CFO | 01.01.2006 |
XBIOTECH INC. | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
XBIOTECH INC. | Health Technology |
AMGEN INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Keane Consulting, Inc. | |
Elanco Tiergesundheit AG
Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Health Technology |